0001062993-19-002518.txt : 20190605
0001062993-19-002518.hdr.sgml : 20190605
20190605135025
ACCESSION NUMBER: 0001062993-19-002518
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190603
FILED AS OF DATE: 20190605
DATE AS OF CHANGE: 20190605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CALDWELL PATRICK M
CENTRAL INDEX KEY: 0001242121
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 19879342
MAIL ADDRESS:
STREET 1: C/O PROTINE DESIGN LAB
STREET 2: 532 BELLA CALAIS WAY
CITY: SAN JOSE
STATE: CA
ZIP: 94138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2019-06-03
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001242121
CALDWELL PATRICK M
C/O BIOSPECIFICS TECHNOLOGIES CORP.
35 WILBUR STREET
LYNBROOK
NY
11563
0
1
0
0
Principal Financial Officer
Common Stock, $0.001 par value
2019-06-03
4
S
0
6000
58.8
D
0
D
The selling price of $58.80 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $58.50 to $59.19. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Patrick M. Caldwell, by Carl A. Valenstein, attorney-in-fact
2019-06-05